Back to DNLI
Casdin Capital, LLC DNLI Position History
Denali Therapeutics Inc. • Healthcare
Quarters held
4
Latest value
$25.8M
Q3 2026
Peak value
$52.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $30.4M |
| Q1 2026 | $35.3M |
| Q2 2026 | $52.6M |
| Q3 2026 | $25.8M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $25.8M | 1.25M | — | — |
| Q2 2026 | $52.6M | 2.04M | — | — |
| Q1 2026 | $35.3M | 1.84M | — | — |
| Q4 2025 | $30.4M | 1.84M | — | — |
Other funds holding DNLI
$831.4M
$723.7M
$653.8M
$619.1M
$610.5M
$561.5M
$528.6M